Last update 23 Jan 2025

Anti CD19 chimeric antigen receptor T cell therapy(Beijing Boren Hospital)

Overview

Basic Info

Drug Type
CAR-T
Synonyms-
Target
CD19
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
Autoimmune DiseasesAcute Lymphoblastic Leukemia
Inactive Indication-
Originator Organization
Beijing Gaobo Boren Hospital Co., Ltd.Beijing Gaobo Boren Hospital Co., Ltd.
Active Organization
Beijing Gaobo Boren Hospital Co., Ltd.Beijing Gaobo Boren Hospital Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Anti CD19 chimeric antigen receptor T cell therapy(Beijing Boren Hospital)
NCT06688799
/ RecruitingPhase 1/2
A Single-Center, Open-Label, Non-Randomized, Single-Arm Clinical Study on the Treatment of Refractory Autoimmune Diseases With CD19-CAR T Cells
ChiCTR1900024456
/ RecruitingEarly Phase 1
Phase I study for autologous anti-CD19 (human derived) chimeric antigen receptor T cells treating refractory or relapsed acute lymphoblastic leukemia
100 Clinical Results associated with Anti CD19 chimeric antigen receptor T cell therapy(Beijing Boren Hospital)
Login to view more data
100 Translational Medicine associated with Anti CD19 chimeric antigen receptor T cell therapy(Beijing Boren Hospital)
Login to view more data
100 Patents (Medical) associated with Anti CD19 chimeric antigen receptor T cell therapy(Beijing Boren Hospital)
Login to view more data
100 Deals associated with Anti CD19 chimeric antigen receptor T cell therapy(Beijing Boren Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Autoimmune DiseasesPhase 2
CN
Beijing Gaobo Boren Hospital Co., Ltd.Beijing Gaobo Boren Hospital Co., Ltd.
23 Nov 2024
Acute Lymphoblastic LeukemiaPhase 1
CN
Beijing Gaobo Boren Hospital Co., Ltd.Beijing Gaobo Boren Hospital Co., Ltd.
03 Jul 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free